498 related articles for article (PubMed ID: 32065356)
1. Lefty-1 inhibits renal epithelial-mesenchymal transition by antagonizing the TGF-β/Smad signaling pathway.
Zhang L; Liu X; Liang J; Wu J; Tan D; Hu W
J Mol Histol; 2020 Feb; 51(1):77-87. PubMed ID: 32065356
[TBL] [Abstract][Full Text] [Related]
2. Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells.
Mariasegaram M; Tesch GH; Verhardt S; Hurst L; Lan HY; Nikolic-Paterson DJ
Biochem Biophys Res Commun; 2010 Mar; 393(4):855-9. PubMed ID: 20171171
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway.
Bai Y; Lu H; Wu C; Liang Y; Wang S; Lin C; Chen B; Xia P
Biochem Pharmacol; 2014 Dec; 92(3):484-93. PubMed ID: 25219324
[TBL] [Abstract][Full Text] [Related]
5. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
[TBL] [Abstract][Full Text] [Related]
6. Lefty1 alleviates renal tubulointerstitial injury in mice with unilateral ureteral obstruction.
Xu C; Xu M; Wang W; Zhang J
Mol Med Rep; 2016 Jan; 13(1):901-8. PubMed ID: 26647776
[TBL] [Abstract][Full Text] [Related]
7. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
8. Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway.
Liu X; Sun N; Mo N; Lu S; Song E; Ren C; Li Z
Food Funct; 2019 Jun; 10(6):3782-3797. PubMed ID: 31180394
[TBL] [Abstract][Full Text] [Related]
9. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
Cai P; Liu X; Xu Y; Qi F; Si G
Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
[TBL] [Abstract][Full Text] [Related]
10. Lefty A protein inhibits TGF-β1-mediated apoptosis in human renal tubular epithelial cells.
Zheng RP; Bai T; Zhou XG; Xu CG; Wang W; Xu MW; Zhang J
Mol Med Rep; 2013 Aug; 8(2):621-5. PubMed ID: 23807264
[TBL] [Abstract][Full Text] [Related]
11. Total flavonoids from Smilax glabra Roxb blocks epithelial-mesenchymal transition and inhibits renal interstitial fibrosis by targeting miR-21/PTEN signaling.
Luo Q; Cai Z; Tu J; Ling Y; Wang D; Cai Y
J Cell Biochem; 2019 Mar; 120(3):3861-3873. PubMed ID: 30304552
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated P311 inhibits TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells via TGF-β1-Smad-ILK pathway.
Qi F; Cai P; Liu X; Peng M; Si G
Biosci Trends; 2015 Oct; 9(5):299-306. PubMed ID: 26559022
[TBL] [Abstract][Full Text] [Related]
13. Lefty A attenuates the TGF-beta1-induced epithelial to mesenchymal transition of human renal proximal epithelial tubular cells.
Li Y; Zhang J; Fang L; Luo P; Peng J; Du X
Mol Cell Biochem; 2010 Jun; 339(1-2):263-70. PubMed ID: 20157767
[TBL] [Abstract][Full Text] [Related]
14. Anti-fibrotic effects of synthetic TGF-β1 and Smad oligodeoxynucleotide on kidney fibrosis in vivo and in vitro through inhibition of both epithelial dedifferentiation and endothelial-mesenchymal transitions.
Gwon MG; An HJ; Kim JY; Kim WH; Gu H; Kim HJ; Leem J; Jung HJ; Park KK
FASEB J; 2020 Jan; 34(1):333-349. PubMed ID: 31914629
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
17. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
18. Alpha-mangostin alleviate renal interstitial fibrosis via suppression of TGF-β1/Smad/ERK signaling axis in vitro and in vivo.
Juan YH; Yu YL; Tsai YP; Lee CC; Chen YS; Ting YH; Tsai JP; Hsieh YH
Biochem Pharmacol; 2023 Dec; 218():115935. PubMed ID: 37989414
[TBL] [Abstract][Full Text] [Related]
19. Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.
Liu L; Wang Y; Yan R; Li S; Shi M; Xiao Y; Guo B
PLoS One; 2016; 11(3):e0151986. PubMed ID: 27010330
[TBL] [Abstract][Full Text] [Related]
20. ILK participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via TGF-β1/smad pathway.
Li M; Zhou H; Di J; Yang M; Jia F
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):289-296. PubMed ID: 30657569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]